TrialProceedings of the National Academy of Sciences of the United States of America1998

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.

R Soiffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.